Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Rattanaumpawan, Pinyo ^a   Ussavasodhi, Prapassorn ^a   Kiratisin, Pattarachai ^a   Aswapokee, Nalinee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Acinetobacter baumannii; Bacteremia; Epidemiology; Non fermentative gram negative bacteria; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD CULTURE; BURKHOLDERIA PSEUDOMALLEI; CATHETER INFECTION; CAUSAL ATTRIBUTION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GRAM NEGATIVE SEPSIS; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PRIMARY INFECTION; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THAILAND;

ADULT; AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THAILAND; VANCOMYCIN;

EID: 84875834994     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-167     Document Type: Article

References (27)

1. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271(20):1598-1601. 10.1001/jama.1994.03510440058033, 8182812.
2. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999, 29(2):239-244. 10.1086/520192, 10476719.
3. Chayakulkeeree M, Thamlikitkul V. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever. J Med Assoc Thai 2003, 86(3):212-223.
4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39(3):309-317. 10.1086/421946, 15306996.
5. Enoch DA, Birkett CI, Ludlam HA. Non-fermentative Gram-negative bacteria. Int J Antimicrob Agents 2007, 29(Suppl 3):S33-S41.
6. Daxboeck F, Assadian O, Blacky A, Koller W, Hirschl AM. Resistance of gram-negative non-fermentative bacilli causing bloodstream infection, Vienna, 1996-2003. Eur J Clin Microbiol Infect Dis 2004, 23(5):415-416. 10.1007/s10096-004-1118-4, 15112063.
7. Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, Lopez MJ, Soriano A, Horcajada JP, Gatell JM. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. QJM 2003, 96(3):227-234. 10.1093/qjmed/hcg031, 12615987.
8. Steinberg J, Burd E. Other gram-negative and gram-variable bacilli. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Volume 2 2009, 3015-3033. Philadelphia: Churchill Livingstone, Mandell G, Bennett J, Dolin R, 7.
9. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002, 8(11):687-693. 10.1046/j.1469-0691.2002.00487.x, 12445005.
10. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M. Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008, 27(11):1045-1051. 10.1007/s10096-008-0545-z, 18528721.
11. Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?. Clin Infect Dis 2009, 48(5):580-586. 10.1086/596709, 19191643.
12. Kiratisin P, Li L, Murray PR, Fischer SH. Identification of bacteria recovered from clinical specimens by 16S rRNA gene sequencing. Eur J Clin Microbiol Infect Dis 2003, 22(10):628-631.
13. Apisarnthanarak A, Kiratisin P, Mundy LM. Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer. Diagn Microbiol Infect Dis 2005, 53(2):153-155. 10.1016/j.diagmicrobio.2005.05.014, 16168615.
14. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement: M100-S18 2008, Wayne, PA: CLSI, Clinical and Laboratory Standards Institute.
15. Clinical and Laboratory Standards Institute Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline-Second Edition: M45-A2 2010, Wayne, PA: CLSI, Clinical and Laboratory Standards Institute.
16. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters http://www.eucast.org/, European Committee on Antimicrobial Susceptibility Testing.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16(3):128-140. 10.1016/0196-6553(88)90053-3, 2841893.
18. Hortiwakul T, Nagij S, Chusri S, Silpapojakul K. Nosocomial bloodstream infection in songklanagarind hospital: outcome and factors influencing prognosis. J Med Assoc Thai 2012, 95(2):170-174.
19. Wendt C, Messer SA, Hollis RJ, Pfaller MA, Wenzel RP, Herwaldt LA. Molecular epidemiology of gram-negative bacteremia. Clin Infect Dis 1999, 28(3):605-610. 10.1086/515151, 10194086.
20. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(Suppl 2):ii55-ii63.
21. Seifert H, Strate A, Schulze A, Pulverer G. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases. Clin Infect Dis 1993, 17(4):632-636. 10.1093/clinids/17.4.632, 8268343.
22. Capone A, D'Arezzo S, Visca P, Petrosillo N. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2008, 62(2):422-423. 10.1093/jac/dkn172, 18424790.
23. Moland ES, Craft DW, Hong SG, Kim SY, Hachmeister L, Sayed SD, Thomson KS. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy. Antimicrob Agents Chemother 2008, 52(8):2940-2942. 10.1128/AAC.01581-07, 2493109, 18519722.
24. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005, 18(2):383-416. 10.1128/CMR.18.2.383-416.2005, 1082802, 15831829.
25. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008, 14(11):1041-1047. 10.1111/j.1469-0691.2008.02089.x, 19040476.
26. Blot S, Cankurtaran M, Petrovic M, Vandijck D, Lizy C, Decruyenaere J, Danneels C, Vandewoude K, Piette A, Vershraegen G. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients. Crit Care Med 2009, 37(5):1634-1641. 10.1097/CCM.0b013e31819da98e, 19325489.
27. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, Ko WC. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007, 28(6):713-719. 10.1086/517954, 17520546.